SCHEMBL7101763

SCHEMBL7101763

CC(=O)OC1Cc2ccc(N)cc2C1NC(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
PRKCG P05129 4/20 0.42
PRKCB P05771 4/20 0.42
PRKCD Q05655 4/20 0.42
PRKCE Q02156 3/20 0.42
PRKCA P17252 2/20 0.42
PRKACA P17612 2/20 0.42
PRKACG P22612 2/20 0.42
PRKACB P22694 2/20 0.42
PRKCH P24723 1/20 0.42
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.37
CHRM1 P11229 4/20 0.36
GAA P10253 1/20 0.36
CTSS P25774 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101760 1.00 KDM4E (0.48) KDM4EPRKCGPRKCBPRKCDPRKCE
SCHEMBL7107509 0.85 KDM4E (0.47) KDM4EPRKCGPRKCBPRKCDPRKCE
SCHEMBL7107511 0.83 KDM4E (0.45) KDM4EPRKCGPRKCBPRKCDPRKCE
SCHEMBL7107514 0.83 KDM4E (0.45) KDM4EPRKCGPRKCBPRKCDPRKCE
SCHEMBL6358461 0.75 TAS1R3 (0.42) CTSS
SCHEMBL4870913 0.74 CHRM1 (0.53) MAPTALDH1A1CHRM1CHRM2CHRM4
SCHEMBL4868985 0.74 CHRM1 (0.53) MAPTALDH1A1CHRM1CHRM2CHRM4
SCHEMBL4868987 0.74 CHRM1 (0.53) MAPTALDH1A1CHRM1CHRM2CHRM4
SCHEMBL7149111 0.73 GAA (0.43) KDM4EMAPTALDH1A1GAAHTT
SCHEMBL5115602 0.69 CHRM1 (0.56) CHRM1CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923543-B1 POTASSIUM CHANNEL INHIBITORS ICAGEN INC (US) 2003-09-24 EP disclosed
US-6083986-A Potassium channel inhibitors ICAGEN, INC. (US) 2000-07-04 US disclosed